The new HPV (cervical cancer) vaccine is now available for women between the ages of 16 and 26 at the Sloane Street Gynaecology Clinic. Parents wishing to vaccinate children between the ages of 9 and 16 will be referred to another doctor as minors are not seen in the clinic. Women should ring 020 7201 2667 for an appointment. Prices are listed at the bottom of this page.
The HPV vaccine is for the prevention of cervical cancer and other diseases caused by the human papillomviruses (HPV) types 6, 11, 16, and 18.
Who the vaccine is for
The HPV vaccine is of proven value in women between the ages of 16 and 26 and children from the ages of 9 to 15. There is no evidence to support the administration of the vaccine to men.
The vaccine is of no value for the prevention of CIN and cervix cancer to women who have tested positive to HPV type 16 and 18. However, it may be of value in preventing type 16 associated CIN in women who have tested positive to HPV type 18 and vice versa.
The safety of the vaccine is untested in pregnant women.
Effectiveness of the vaccine
The vaccine is best administered to women who have not been exposed to HPV. In other words, women who are virgins will benefit the most. Early studies suggest that the vaccine may be almost 100% effective for the prevention of type 16 and 18 CIN in virgins. In other women whose HPV status is not known, there is an overall 39% protection against type 16 and 18 CIN.
It should be noted that only 75% of all cervix cancers are caused by the HPV viruses 16 an 18 and it is therefore still possible for a woman to develop cervix cancer even though they are immunised.
How it is given
Women receive three injections over a six month period. It is not known when a booster is required. It is known to last four and a half years but may last longer.
At the Sloane Street Clinic we have a policy to perform a pregnancy test before each vaccine in sexually active women. We also have a policy to perform cervical HPV testing before a vaccine course and as part of follow-up in sexually active women.
It is essential that a woman still has her regular smear tests following vaccination. The vaccine only reduces the risk of cervix cancer. It does not completely prevent it.
Of 11,000 women who have received the vaccine in trials, the most common side effect was a temperature for a day after administration. Pain and swelling around the injection site was also very common. Very rarely, a woman may have an allergic reaction to the vaccine.
Please contact us for the latest prices.
Sexually active patients are encouraged to return annually for HPV testing or to see their private GP to have this done. This type of HPV testing is not currently available in the NHS.
Patients may wish to have a consultation in addition to their vaccination. Additional fees apply.
* Vaccine will not be administered to women who are positive to HPV types 16 and 18. Instead these women will be given a consultation with a specialist and repeat testing at 6 months if appropriate. If a woman is positive to one type she will have a consultation with the nurse and given the opportunity to have a consultation with a specialist or continuation of the vaccination programme. If a woman choses to have a consultation with a specialist, an additional charge will be made if she chooses to proceed with vaccination. The vaccine will not be administered in the abscence of a negative pregnancy test irrespective of contraception or recent sexual activity.
** If a woman has an abnormal smear she may be referred to colposcopy or advised to have a consultation.